126 related articles for article (PubMed ID: 35151913)
1. North Carolina Macular Dystrophy: Long-term Follow-up of the Original Family.
Small KW; Wiggins R; Udar N; Silva-Garcia R; Avetisjan J; Vincent A; Shaya FS
Ophthalmol Retina; 2022 Jun; 6(6):512-519. PubMed ID: 35151913
[TBL] [Abstract][Full Text] [Related]
2. Multimodal Imaging and Functional Testing in a North Carolina Macular Disease Family: Toxoplasmosis, Fovea Plana, and Torpedo Maculopathy Are Phenocopies.
Small KW; Tran EM; Small L; Rao RC; Shaya F
Ophthalmol Retina; 2019 Jul; 3(7):607-614. PubMed ID: 31043363
[TBL] [Abstract][Full Text] [Related]
3. A novel tandem duplication of PRDM13 in a Chinese family with North Carolina macular dystrophy.
Wu S; Yuan Z; Sun Z; Zhu T; Wei X; Zou X; Sui R
Graefes Arch Clin Exp Ophthalmol; 2022 Feb; 260(2):645-653. PubMed ID: 34427740
[TBL] [Abstract][Full Text] [Related]
4. North Carolina macular dystrophy shows a particular drusen phenotype and atrophy progression.
Birtel J; Gliem M; Herrmann P; Neuhaus C; Holz FG; MacLaren RE; Scholl HPN; Charbel Issa P
Br J Ophthalmol; 2022 Sep; 106(9):1269-1273. PubMed ID: 33785507
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic characterization of a Danish family with North Carolina macular dystrophy.
Rosenberg T; Roos B; Johnsen T; Bech N; Scheetz TE; Larsen M; Stone EM; Fingert JH
Mol Vis; 2010 Dec; 16():2659-68. PubMed ID: 21179233
[TBL] [Abstract][Full Text] [Related]
6. North Carolina Macular Dystrophy Is Caused by Dysregulation of the Retinal Transcription Factor PRDM13.
Small KW; DeLuca AP; Whitmore SS; Rosenberg T; Silva-Garcia R; Udar N; Puech B; Garcia CA; Rice TA; Fishman GA; Héon E; Folk JC; Streb LM; Haas CM; Wiley LA; Scheetz TE; Fingert JH; Mullins RF; Tucker BA; Stone EM
Ophthalmology; 2016 Jan; 123(1):9-18. PubMed ID: 26507665
[TBL] [Abstract][Full Text] [Related]
7. A novel duplication involving
Small KW; Van de Sompele S; Nuytemans K; Vincent A; Yuregir OO; Ciloglu E; Sariyildiz C; Rosseel T; Avetisjan J; Udar N; Vance JM; Pericak-Vance MA; De Baere E; Shaya FS
Mol Vis; 2021; 27():518-527. PubMed ID: 34526759
[TBL] [Abstract][Full Text] [Related]
8. North Carolina Macular Dystrophy: Phenotypic Variability and Computational Analysis of Disease-Associated Noncoding Variants.
Green DJ; Lenassi E; Manning CS; McGaughey D; Sharma V; Black GC; Ellingford JM; Sergouniotis PI
Invest Ophthalmol Vis Sci; 2021 Jun; 62(7):16. PubMed ID: 34125159
[TBL] [Abstract][Full Text] [Related]
9. Congenital toxoplasmosis as one phenocopy of North Carolina Macular Dystrophy (NCMD/MCDR1).
Small KW; Vincent AL; Knapper CL; Shaya FS
Am J Ophthalmol Case Rep; 2019 Sep; 15():100521. PubMed ID: 31367689
[TBL] [Abstract][Full Text] [Related]
10. New Noncoding Base Pair Mutation at the Identical Locus as the Original NCMD/MCDR1 in a Mexican Family, Suggesting a Mutational Hotspot.
Small KW; Van de Sompele S; Avetisjan J; Udar N; Agemy S; De Baere E; Shaya FS
J Vitreoretin Dis; 2023; 7(1):33-42. PubMed ID: 37008391
[TBL] [Abstract][Full Text] [Related]
11. North Carolina macular dystrophy (MCDR1) caused by a novel tandem duplication of the
Bowne SJ; Sullivan LS; Wheaton DK; Locke KG; Jones KD; Koboldt DC; Fulton RS; Wilson RK; Blanton SH; Birch DG; Daiger SP
Mol Vis; 2016; 22():1239-1247. PubMed ID: 27777503
[TBL] [Abstract][Full Text] [Related]
12. A unique
Namburi P; Khateb S; Meyer S; Bentovim T; Ratnapriya R; Khramushin A; Swaroop A; Schueler-Furman O; Banin E; Sharon D
Mol Vis; 2020; 26():299-310. PubMed ID: 32476814
[TBL] [Abstract][Full Text] [Related]
13. A reappraisal of the clinical spectrum of North Carolina macular dystrophy.
Khurana RN; Sun X; Pearson E; Yang Z; Harmon J; Goldberg MF; Zhang K
Ophthalmology; 2009 Oct; 116(10):1976-83. PubMed ID: 19616854
[TBL] [Abstract][Full Text] [Related]
14. North Carolina macular dystrophy, revisited.
Small KW
Ophthalmology; 1989 Dec; 96(12):1747-54. PubMed ID: 2622620
[TBL] [Abstract][Full Text] [Related]
15. The possible pathogenesis of macular caldera in patients with North Carolina macular dystrophy.
Zhu Z; Zou H; Li C; Tong B; Zhang C; Xiao J
BMC Ophthalmol; 2022 Nov; 22(1):447. PubMed ID: 36402981
[TBL] [Abstract][Full Text] [Related]
16. Thirty-Year follow-up of an African American family with macular dystrophy of the retina, locus 1 (North Carolina macular dystrophy).
Kiernan DF; Shah RJ; Hariprasad SM; Grassi MA; Small KW; Kiernan JP; Mieler WF
Ophthalmology; 2011 Jul; 118(7):1435-43. PubMed ID: 21310494
[TBL] [Abstract][Full Text] [Related]
17. Genetic linkage studies of a North Carolina macular dystrophy family.
Audere M; Rutka K; Inaskina I; Peculis R; Sepetiene S; Valeina S; Lāce B
Medicina (Kaunas); 2016; 52(3):180-6. PubMed ID: 27496188
[TBL] [Abstract][Full Text] [Related]
18. Best Vitelliform Macular Dystrophy (BVMD) is a phenocopy of North Carolina Macular Dystrophy (NCMD/MCDR1).
Small KW; Jampol LM; Bakall B; Small L; Wiggins R; Agemy S; Udar N; Avetisjan J; Vincent A; Shaya FS
Ophthalmic Genet; 2021 Dec; ():1-11. PubMed ID: 34895015
[TBL] [Abstract][Full Text] [Related]
19. Two novel non-coding single nucleotide variants in the DNase1 hypersensitivity site of
Seo Y; Joo K; Lee J; Diaz A; Jang S; Cherry TJ; Bujakowska KM; Han J; Woo SJ; Small KW
Mol Vis; 2024; 30():58-66. PubMed ID: 38601016
[TBL] [Abstract][Full Text] [Related]
20. Multi-omics approach dissects cis-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathy.
Van de Sompele S; Small KW; Cicekdal MB; Soriano VL; D'haene E; Shaya FS; Agemy S; Van der Snickt T; Rey AD; Rosseel T; Van Heetvelde M; Vergult S; Balikova I; Bergen AA; Boon CJF; De Zaeytijd J; Inglehearn CF; Kousal B; Leroy BP; Rivolta C; Vaclavik V; van den Ende J; van Schooneveld MJ; Gómez-Skarmeta JL; Tena JJ; Martinez-Morales JR; Liskova P; Vleminckx K; De Baere E
Am J Hum Genet; 2022 Nov; 109(11):2029-2048. PubMed ID: 36243009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
